BlackRock, Inc. 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 3,977,535 7.300% | 2,008,751 (+102.03%) | Filing |
| 2024-09-10 12:09 pm Sale | 2024-08-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 1,968,784 3.700% | -1,870,591 (-48.72%) | Filing |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 3,839,375 7.300% | -2,799,039 (-42.16%) | Filing |
| 2024-06-07 1:30 pm Sale | 2024-05-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 6,638,414 12.700% | -2,760,783 (-29.37%) | Filing |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 9,399,197 18.100% | 17,305 (+0.18%) | Filing |
| 2023-11-07 3:33 pm Purchase | 2023-10-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 9,381,892 18.100% | 2,981,689 (+46.59%) | Filing |
| 2023-09-07 09:38 am Sale | 2023-08-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 6,400,203 12.400% | -2,555,015 (-28.53%) | Filing |
| 2023-01-26 08:43 am Unchanged | 2022-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,955,218 18.000% | 0 (Unchanged) | Filing |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,955,218 18.000% | 878,317 (+10.87%) | Filing |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,076,901 15.000% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,076,901 15.000% | 2,713,394 (+50.59%) | Filing |
| 2021-03-09 6:37 pm Purchase | 2021-02-28 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 5,363,507 10.100% | 86,559 (+1.64%) | Filing |
| 2021-01-29 09:56 am Sale | 2020-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 5,276,948 9.950% | -1,543,320 (-22.63%) | Filing |